Zulfa, Ilil Maidatuz and Yunitasari, Fitria Dewi and Dewi, Susanty Kartika (2020) Potential Drug-drug Interactions Analysis in Children Out-patients with Bronchopneumonia Medication Prescriptions. Borneo Journal of Pharmacy, 3 (2). ISSN e-ISSN: 2621-4814
Text
1316-Article Text-5463-1-10-20200521.pdf Download (202kB) |
|
Text
Similarity IO BJoP.pdf Download (1MB) |
|
Text
FIX_Rev_Penilaian Sejawat Sebidang_BJoP IO.pdf Download (65kB) |
Abstract
Drug-drug interactions (DDIs) is defined as the alteration of efficacy and toxicity of some drugs in the presence of other drugs. In the treatments of bronchopneumonia in outpatient settings, there is a lack of documentation of DDIs. This study was aimed to observe the potential DDIs on the prescriptions of children with bronchopneumonia. An observational and cross-sectional study was conducted on outpatient children with bronchopneumonia prescriptions during 2017. Potential for DDI was identified by online drug interaction checkers. The potential DDI then classified based on its severity (minor, moderate, and major) and mechanism (pharmacokinetic and pharmacodynamic). Among 86 prescriptions analyzed, potential DDIs observed at 48.84% of it. Of that, there were 67 potential DDIs where 72.34% of it were categorized as moderate. The majority of potential DDIs was pharmacodynamic interaction (76.12%) with the most frequently involved drug pair was Ephedrine- Salbutamol (29.85%). Children outpatients with bronchopneumonia are at risk of potential DDIs, especially to minor and moderate potential DDIs. Prescriptions screening for potential DDIs followed by monitoring of therapeutical effects and associated adverse drug events will optimize patient safety.
Item Type: | Article |
---|---|
Subjects: | Kesehatan > Farmasi > Farmasi Klinis Komunitas dan Manajemen Farmasi |
Depositing User: | Elvia Ikasari |
Date Deposited: | 22 Dec 2020 08:19 |
Last Modified: | 29 Dec 2020 04:05 |
URI: | http://repository.akfarsurabaya.ac.id/id/eprint/231 |
Actions (login required)
View Item |